InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (10 ops.)
Explore the full record of transactions filed by Harris Erik, Vice-Président Exécutif et Directeur Commercial. Insider active across 2 companies, notably Ultragenyx Pharmaceutical Inc.. In total, 12 filings have been recorded. Total volume traded: €404k. The latest transaction was filed on 19 June 2022 — Cession. Regulator: SEC (Form 4). All data is free.
Declarations12 total
€15,403295 shares@ €52.21410.0006% mcap3.8% of flow
Common Stock
SEC:0001209191-22-038774:0·
€161,1462,713 shares@ €59.39770.0065% mcap39.9% of flow
Common Stock
SEC:0001209191-22-015830:0·
06,869 shares0
Common Stock
SEC:0001714899-22-000024·
06,869 shares0
Common Stock
SEC:0001714899-22-000024:0·
€21,210303 shares@ €69.99950.0009% mcap18.6% of flow
Common Stock
SEC:0001209191-21-060760·
€21,210303 shares@ €69.99950.0009% mcap5.2% of flow
Common Stock
SEC:0001209191-21-060760:0·
€29,028375 shares@ €77.40690.0012% mcap25.5% of flow
Common Stock
SEC:0001209191-21-045972·
€29,028375 shares@ €77.40690.0012% mcap7.2% of flow
Common Stock
SEC:0001209191-21-045972:0·
€34,712437 shares@ €79.43150.0014% mcap30.5% of flow
Common Stock
SEC:0001209191-21-042812·
€34,712437 shares@ €79.43150.0014% mcap8.6% of flow
Common Stock
SEC:0001209191-21-042812:0·
€28,918307 shares@ €94.19520.0012% mcap25.4% of flow
Common Stock
SEC:0001209191-21-031378·
€28,918307 shares@ €94.19520.0012% mcap7.2% of flow
Common Stock
SEC:0001209191-21-031378:0·
12 of 12 declarations
About Harris Erik
Harris Erik is the Executive Vice President and Chief Commercial Officer of Ultragenyx Pharmaceutical Inc. and Denali Therapeutics Inc. In these roles, he is responsible for commercial strategy and business development, contributing to the growth of both companies in the biopharmaceutical sector.
